Source link : https://www.newshealth.biz/health-news/is-wegovy-shrinking-bariatric-surgery-too/
N. Adam Brown is a practicing emergency physician, entrepreneur, and healthcare executive. He is the founder of ABIG Health, a healthcare growth strategy firm, and a professor at the University of North Carolina’s Kenan-Flagler Business School. Follow Glucagon-like peptide 1 (GLP-1) receptor agonists like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), were originally approved for […]
Author : News Health
Publish date : 2024-09-19 16:44:33
Copyright for syndicated content belongs to the linked Source.